Clinical Trial Update: Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) [Phase 1, Phase 2]

View source ↗

Summary

The NivoPlus trial evaluating nivolumab plus chemotherapy in various advanced cancers has been terminated (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Endometrial Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer
• Renal Cell Carcinoma
• Uterine Cancer

Drugs mentioned

• OPDIVO (nivolumab)

Snippet

Sponsor: Western Regional Medical Center | Conditions: Advanced Cancer, Pancreatic Cancer | Phase 1, Phase 2 | Status: TERMINATED